Press release
Peptide CDMO (Pharmaceutical) Market Boosted by Rising Investments in Personalized and Precision Medicine
Peptide CDMO (Pharmaceutical) Market
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1202
Peptide Contract Development and Manufacturing Organizations (CDMOs) focus on the highly controlled production of peptides-short amino acid sequences formed through peptide bonds-using precise and specialized manufacturing processes. Their operations require the accurate assembly of amino acids in predetermined sequences while maintaining the integrity of functional groups to ensure the desired structural and biological properties. Peptide manufacturing is conducted through multiple advanced techniques, including solid-phase synthesis, solution-phase synthesis, and recombinant DNA-based methods.
The rising global incidence of chronic diseases has amplified the need for advanced therapeutic modalities. Peptide-based drugs offer significant clinical advantages, such as high target specificity, the ability to modulate essential biochemical pathways, and reduced dosing requirements. As a result, the adoption of peptide therapeutics continues to expand across therapeutic areas including oncology, cardiovascular care, and metabolic disorders. CDMOs are instrumental in supporting this growth by delivering specialized expertise in both the development and large-scale manufacturing of peptide-based pharmaceutical products.
List of Prominent Players in the Peptide CDMO (Pharmaceutical) Market:
• AmbioPharm
• Auspep
• Bachem
• BCN Peptide
• CPC Scientific
• CBL- Chemical and Biopharmaceutical Laboratories
• Creative Peptides
• Chinese Peptide
• CSBio
• Corden Pharma
• PolyPeptide
• Hybio Pharmaceutical
• Peptide Institute
• Pepscan
• Almac
• Vivitide
• CreoSalus Inc
• ScinoPharm
• Senn Chemicals
• Wuxi AppTec
• Olon
• Belyntic
• Ferring Pharma
• Numaferm
• Hybio Pharmaceutical
• Provepharm Life Solutions
• Enzene Biosciences
• Ardena Holding
• Stelis Biopharma
• Piramal Pharma
• Space Peptides Pharmaceutical
Read Overview Report- https://www.insightaceanalytic.com/report/global-peptide-cdmo-pharmaceutical-market-/1202
Market Dynamics
Drivers
The global peptide CDMO (pharmaceutical) services market is experiencing steady expansion, driven by the increasing adoption of peptide-based therapeutics, continuous technological progress in biopharmaceutical development, and growing interest from pharmaceutical manufacturers in peptide drug pipelines. The rising prevalence of chronic diseases, alongside heightened consumer focus on health and wellness, continues to strengthen demand for peptide-based treatments.
To improve operational efficiency, production scalability, and product quality, pharmaceutical companies are increasingly engaging in strategic collaborations with CDMOs. These partnerships enable enhanced development, engineering, and manufacturing capabilities. Collectively, these factors are expected to support sustained market growth throughout the forecast period.
Challenges
Despite the market's promising outlook, several challenges may impede growth. Peptide manufacturing is technically demanding and requires advanced equipment and highly specialized expertise, making the process substantially more complex than the production of traditional small-molecule drugs. These technical hurdles, combined with growing global demand, highlight the need for more scalable and cost-efficient manufacturing solutions. High production costs may also restrict access to peptide therapies in certain regions.
Additionally, limitations in current drug-delivery systems-for example, cell-penetrating peptides that deliver only a portion of the administered dose to target cells-can diminish therapeutic effectiveness due to metabolic degradation. The COVID-19 pandemic further exposed vulnerabilities in supply chains, workforce availability, and demand forecasting, underscoring the importance of robust operational planning and resource management across the CDMO industry.
Regional Trends
North America is anticipated to command a significant share of global peptide CDMO revenue, supported by rapid advancements in biosynthesis technologies and the continued expansion of the chemical and pharmaceutical sectors. Strong investment in research areas such as genomics, personalized medicine, and targeted therapeutics is also driving demand for specialized CDMO capabilities.
Europe remains another prominent regional market, characterized by a sizable patient population, increasing healthcare expenditure, and active participation from multinational pharmaceutical companies pursuing peptide-focused development initiatives.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1202
Recent Developments:
• In March 2024, Ferring Pharmaceuticals and SK Pharmateco reached a partnership to increase the industrial production capability of Adstiladrin (nadofaragene firadenovec-vncg), the medication used in Ferring's intravesical genetic therapy.
• In August 2024, AmbioPharma revealed its selection of Brian Gregg, a business veteran, as its new CEO. Mr. Gregg takes over from Tim Nieters, who is leaving the business after seven seasons and has a long history of expertise in the peptide CDMO sector.
Segmentation of Peptide CDMO (Pharmaceutical) Market-
By Scale of Operation-
• Preclinical
• Clinical
• Commercial
By Method Used-
• Chemical Synthesis Method
• Non-Chemical Synthesis Method
By Applications-
• Peptide Supplements
• Peptide Vaccines
• Peptides as Radio-theranostic Agents
• Cell-penetrating Peptides (CPPs)
• Affinity Ligands
• Protein Mimics
By Synthesis Types-
• LPPS
• SPPS
• Mixed Phase
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: https://www.insightaceanalytic.com/
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peptide CDMO (Pharmaceutical) Market Boosted by Rising Investments in Personalized and Precision Medicine here
News-ID: 4292601 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Carpal Tunnel Release Systems Market Segmentation Covers Products, End-Users, an …
The Carpal Tunnel Release Systems Market Size is valued at 731.38 Million in 2024 and is predicted to reach 2348.29 Million by the year 2034 at a 12.5% CAGR during the forecast period for 2025-2034.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1024
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global carpal tunnel release systems market are:
• Increasing older population
• Increasing healthcare expenditure
• Technological developments in minimally…
Regenerative Agriculture Market Insights Reveal North America Leading Global Rev …
The Global Regenerative Agriculture Market Size is valued at USD 11.74 billion in 2024 and is predicted to reach USD 49.07 billion by the year 2034 at a 15.5% CAGR during the forecast period for 2025-2034.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1623
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global regenerative agriculture market are:
• Growing consciousness of deteriorating soil
• Growing interest in environmentally friendly agricultural methods
• Growing…
Artificial Intelligence/Machine Learning Medical Device Market Growth Fueled by …
The Artificial Intelligence/Machine Learning Medical Device Market Size is valued at 6.10 Billion in 2024 and is predicted to reach 52.09 Billion by the year 2031 at a 24.1% CAGR during the forecast period for 2024-2031.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1789
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global artificial intelligence/machine learning medical device market are:
• Increasing demand for more accurate diagnosis
• Increasing the accessibility…
Biopharmaceutical Excipient Manufacturing Market Experiencing Rapid Growth Drive …
The Biopharmaceutical Excipient Manufacturing Market Size is valued at 2.73 Billion in 2024 and is predicted to reach 4.38 Billion by the year 2034 at a 5.0 % CAGR during the forecast period for 2025-2034.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1197
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global biopharmaceutical excipient manufacturing market are:
• Increasing need for biopharmaceutical and biologic medications
• Increasing healthcare expenditure
• Advancements in…
More Releases for Peptide
Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva …
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growth…
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension…
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights:
• Global Peptide Cancer Drug Market Insight By Region & Indication
• Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion
• Approved Peptide Cancer Drugs: > 30 Drugs
• Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis
• Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase
• Insight On Peptide Cancer Drugs In Clinical Trials: >…
Growing Adoption of Synthetic Peptide Drugs Driving Peptide Therapeutics Market …
Peptide Therapeutics Market size was valued at USD 40.69 billion in 2019 and is poised to grow from USD 43.11 billion in 2023 to USD 68.4 billion by 2031, growing at a CAGR of 5.94% in the forecast period (2024-2031).
[https://www.skyquestt.com/report/peptide-therapeutics-market] size was valued at USD 43.11 billion in 2023 to USD 68.4 billion by 2031, growing at a CAGR of 5.94% in the forecast period (2024-2031). The increasing prevalence of…
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global…
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established…
